Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-23-129185)

Filing Details

Accession Number:: 0001104659-23-129185
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-12-26 16:05:23
Reporting Period:: 2023-12-21

Accepted Time:: 2023-12-26 16:05:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1130166	Cyclacel Pharmaceuticals Inc.	CYCC	Pharmaceutical Preparations (2834)	911766850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1357396	George Spiro Rombotis	C/O Cyclacel Pharmaceuticals, Inc., 200 Connell Drive, Suite 1500 Berkeley Heights NJ 07922	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-12-21	6,070	$3.32	68,658	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants (right to buy)	Acquisiton	2023-12-21	6,070	$0.00	6,070	$3.19

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,070	2023-12-21	2030-12-21	No	4	P	Direct

Footnotes

The Reporting Person purchased unregistered shares of the Issuer's common stock in a private placement, pursuant to a Securities Purchase Agreement between the Reporting Person and the Issuer.
Each share of common stock was purchased with an accompanying warrant at an aggregate purchase price of $3.315 per share and accompanying warrant.